Cymabay Therapeutics Inc (NASDAQ:CBAY)

3.39
BATS BZX Real-Time Price
As of 11:20am ET
 -0.07 / -2.02%
Today’s Change
3.32
Today|||52-Week Range
7.77
-40.94%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.0010.0M0.00
 
 
Depreciation And Amortization22.0K29.0K35.0K105.0K
 
 
 
 
 
 
Operating ExpensesGross Income-22.0K-29.0K---105.0K
 
 
 
 
General Expenses25.9M25.6M31.3M72.4M
 
 
 
 
 
Research And Development17.0M15.9M18.9M58.1M
 
 
 
 
 
Total Operating Expenses25.9M25.6M31.3M72.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-25.9M-25.6M-21.3M-72.5M
 
 
 
 
 
Extraordinary Credit11.1M76.0K0.000.00
 
 
 
Extraordinary Charge0.000.00-5.8M-407.0K
 
 
 
Interest Expense On Debt913.0K1.3M1.1M336.0K
 
 
 
 
 
Other Expenses0.000.000.00-3.3M
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.5M-26.7M-27.6M-72.5M
 
 
 
 
 
Net Income-15.5M-26.7M-27.6M-72.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS18.9M23.4M34.9M57.8M
 
 
 
 
 
Shares To Calculate EPS Diluted18.9M23.4M34.9M57.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.83-$1.14-$0.79-$1.26
 
 
 
 
 
EPS Diluted-$0.83-$1.14-$0.79-$1.25